Altitude Investment Management
VC Fund
New York, United States
Altitude Investment Management is a VC fund in New York focused on Cannabis and Market Research. Altitude is a New York-based venture capital fund manager focused on the global cannabis industry. The manager's strategy is to invest in a range of early to growth stage companies in North America and Europe that support this rapidly growing industry. Our principals have spent their careers launching and managing alternative investmentfunds, including distressed debt and leveraged credit strategies. We have been involved in highly-regulated industries for decades, and this experience makes our leadership team uniquely qualified to face the regulatory and funding challenges within the cannabis industry.Having invested in the cannabis industry for more than three years, Altitude has deep relationships with legal and regulatory professionals, CEOs of cannabis companies, industry organizations, and consultants.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Altitude Investment Management invests in
Stages Altitude Investment Management invests in
Countries Altitude Investment Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Christian Mark
|
|||
John Brecker
|
|||
Jon Trauben
|
|||
Michael Goldberg
|
|||
Roderick Stephan
|
Investment Focus
Industry
- Cannabis 2 (67%)
- Market Research 2 (67%)
- Flowers 1 (33%)
- Analytics 1 (33%)
- Agriculture 1 (33%)
Stage
- Series C 2 (67%)
- Series B 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Christian Mark
Director of Marketing & Investor Relations
|
Director of Marketing & Investor Relations | Total investments: 0 | Find email | |
|
John Brecker
Partner
|
Partner | Total investments: 0 | Find email | |
|
Jon Trauben
Partner
|
Partner | Total investments: 0 | Find email | |
|
Michael Goldberg
Partner
|
Partner | Total investments: 0 | Find email | |
|
Roderick Stephan
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PathogenDx
|
PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $7.5M / Series B / Sep 30, 2019 | |
BDSA
|
BDSA they provides retailers, manufacturers, brands, wholesalers, and investors with actionable insights to drive profitability, increase revenues, and improve stockholdings. | Series C / Aug 20, 2019 | |
Canndescent
|
Canndescent is a state compliant cultivator of premium cannabis. Canndescent's services include a combination of quality management and deep cultivation expertise and abandons traditional strain names, allowing customers to get cannabis flower produced, packaged, and distributed in accordance with all state and local laws. | $13M / Series C / Sep 07, 2018 |
Co-Investors
7thirty Capital
1 deal together
Arcadian Investment Partners
1 deal together
Cresco Capital Partners
1 deal together
Flatiron Partners
1 deal together
HALLEY Venture Partners
1 deal together
KEY Investment Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Altitude Investment Management invest in?
Altitude Investment Management invests primarily in Cannabis, Market Research and Flowers startups, most often at Series C and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Altitude Investment Management?
Public channels for Altitude Investment Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Altitude Investment Management?
The team at Altitude Investment Management includes Christian Mark (Director of Marketing & Investor Relations), John Brecker (Partner) and Jon Trauben (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
